Volume 48, Issue 11-12 pp. 1271-1281
ORIGINAL ARTICLE

Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death

Cornelius Engelmann

Corresponding Author

Cornelius Engelmann

Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

Institute for Liver and Digestive Health, University College London, London, UK

Correspondence

Cornelius Engelmann, Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany.

Email: [email protected]

Search for more papers by this author
Stefan Schob

Stefan Schob

Department for Neuroradiology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Ines Nonnenmacher

Ines Nonnenmacher

Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Luise Werlich

Luise Werlich

Department for Neuroradiology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Niklas Aehling

Niklas Aehling

Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Sebastian Ullrich

Sebastian Ullrich

Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Thorsten Kaiser

Thorsten Kaiser

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Sandra Krohn

Sandra Krohn

Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Adam Herber

Adam Herber

Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Robert Sucher

Robert Sucher

Department of Visceral, Vascular, Thoracic and Transplant Surgery, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Michael Bartels

Michael Bartels

Department of Visceral, Vascular, Thoracic and Transplant Surgery, University Hospital Leipzig, Leipzig, Germany

HELIOS Park Hospital Leipzig, General-, Visceral- and Vascular Surgery, Leipzig, Germany

Search for more papers by this author
Alexey Surov

Alexey Surov

Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Dirk Hasenclever

Dirk Hasenclever

IMISE – Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany

Search for more papers by this author
Thomas Kahn

Thomas Kahn

Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Daniel Seehofer

Daniel Seehofer

Department of Visceral, Vascular, Thoracic and Transplant Surgery, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
Michael Moche

Michael Moche

Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany

Diagnostic and Interventional Radiology, Nuernberg, Germany

Search for more papers by this author
Thomas Berg

Thomas Berg

Section Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

Search for more papers by this author
First published: 11 November 2018
Citations: 34

Funding

Cornelius Engelmann is funded by the German Research Foundation (DFG) (EN 1100/2-1). He has an on-going research collaboration with Sequana Medical, Merz Pharmaceutical and Novartis. He received speaker fees from Novartis. Thomas Berg received: Research support from Abbvie, Roche, BMS, Gilead, Novartis, Merck/MSD, Intercept, Janssen, Novartis, Sequana Medical, and Pfizer; provided consultancy, speakers bureau and participated in advisory boards for Abbvie, Alexion, Bayer, Boehringer Ingelheim, BMS, Gilead, GSK, Intercept, Janssen, MSD/Merck, Merz, Novartis, Sequana Medical and Roche. All other authors declared no funding interests.

Cornelius Engelmann, Stefan Schob, Michael Moche and Thomas Berg have contributed equally to this article.
The Handling Editor for this article was Professor Peter Hayes, and it was accepted for publication after full peer-review.

Summary

Background

Loss of skeletal muscle mass is a recognised complication with a prognostic impact in patients with cirrhosis.

Aim

To explore in a retrospective analysis which muscle compartment most reliably predicts the occurrence of cirrhosis-associated complications and if there are gender-related differences.

Methods

795 patients with cirrhosis listed for liver transplantation between 2001 and 2014 met the inclusion and exclusion criteria including an abdominal CT scan (±200). Controls were 109 patients who underwent a CT scan after polytrauma. The paraspinal muscles index (PSMI), the abdominal wall muscles index (AWMI) and its combination skeletal muscle index (SMI) were assessed at L3/L4, normalised to the height (cm2/m2).

Results

62.0% of patients with cirrhosis had alcoholic liver disease, and 70.6% were male. As compared to controls, a reduction in PSMI and SMI but not AWMI was associated with high model of end-stage liver disease (MELD) score, high Child-Pugh class, and the presence or history of cirrhosis-associated complications in males but not females. PSMI independently predicted the occurrence of bacterial infections (HR 0.932), spontaneous bacterial peritonitis (HR 0.901), hepatic encephalopathy (HR 0.961), and hepatorenal syndrome (HR 0.946) by multivariate Cox regression analysis in a gender-independent manner. Post-transplant survival was not associated with the PSMI; neither AWMI nor SMI predicted any clinical endpoints.

Conclusions

This study links muscle wasting in patients with cirrhosis predominantly to males. However, the presence of a low PSMI mass is a gender-independent predictor of developing cirrhosis-associated complications and death. Scores combining the MELD with muscle parameters should be re-validated by utilizing the PSMI.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.